BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 19, 2018
View Archived Issues
When tech and health merge, how will life sciences prevail?
The line between health care and technology is becoming blurred.
Read More
Tracking public companies focused on hot therapeutic markets
Biopharmaceutical companies had no difficulty attracting capital in 2017. In fact, they raised $52 billion – an amount that places the year solidly in second place in terms of annual totals generated by the industry.
Read More
Word on the street
Read More
Week in Washington
Read More
Regulatory submissions, approvals and other actions: February 2018
Read More
Money raised by biotech: 2018 vs. 2017
Read More
Money raised by biotech: Jan. 1 - March 8, 2018
Read More
The week's biggest gainers and losers
Read More
BioWorld stock report for public biotechnology companies
Read More
Week in review
Read More